• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Immunomedics Inc

+ Add to Watchlist

IMMU:US

3.3300 USD 0.1300 4.06%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Immunomedics Inc (IMMU)

Open: 3.2000 Day's Range: 3.1500 - 3.3300 Volume: 588,764
Previous Close: 3.2000 52wk Range: 3.0400 - 7.3500 1-Yr Rtn: -44.03%

Stock Chart for IMMU

No chart data available.
  • IMMU:US 3.3300
  • 1D
  • 1M
  • 1Y
3.2000
Interactive IMMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMMU

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3900
Est. EPS (USD) (06/2015) -0.5170
Est. PEG Ratio -
Market Cap (M USD) 310.07
Shares Outstanding (M) 93.11
30 Day Average Volume 434,447
Price/Book (mrq) 7.8769
Price/Sale (ttm) 30.8581
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0010
Dividend Ex-Date 03/15/2002
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMMU

Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.

David M GoldenbergChairman/Chief Scientific OfcrCynthia L SullivanPresident/CEO
Peter P PfreundschuhVP:Finance/CFOChau ChengSenior Dir:Investor Relations
More Company Profile & Key Executives for IMMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil